Drug classifications

Constipation may occur as an adverse drug reaction. When the patient has constipation as an adverse reaction to another drug, the primary care provider may prescribe a stool softener or another laxative to prevent constipation during the drug therapy. Display 48-2 lists the names of some dm and drug classifications that may cause constipation. 

Most of the drug classifications used to treat ophthalmic conditions have been discussed in previous chapters. The following sections provide a short sum-maiy of these classifications and their implications in ophthalmic use. When appropriate the student is referred to the specific chapter where additional information can be found. The Summary Drug Table Select Ophthalmic Preparations provides examples of the drugs used to treat ophthalmic problems. 

The remaining chapters discuss specific drug classifications and contain a common format. In addition to the learning objectives and key terms, the remaining chapters contain a table indicating the drag classifications and drugs discussed in the chapter. The body of each chapter contains the actions, uses, adverse reactions, contraindications, precautions and interactions of... 

Amidon, G. L., Lennemas, H., Shah, V. P., Crison, J. R. A. A theoretical basis for a biopharmaceutic drug classification the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12, 413 20. 

The following is an example of a bar chart showing patient pain score ratings by treatment. The percentage of patients with each pain rating is displayed for each drug classification. 

Amidon, G. L., The rationale for a biopharmaceutics drug classification, in Biopharmaceutics Drug Classification and International Drug Regulation, Capsugel Library, 1995, pp. 179-194. 

Amidon GL, Lennernas H, Shah VP and Crison JR (1995) A Theoretical Basis for a Biopharmaceutic Drug Classification The Correlation In Vitro Drug Product Dissolution and In Vivo Bioavailability. Pharm Res 12 pp 413-420. 

Neubig, R.R., Spedding, M., Kenakin, T., and Christopoulos, A., International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology, Pharmacol. Rev., 55, 597, 2003. 

Fincham, J., Drug classification of Mississippi adrs. a statewide program to stimulate reporting of adverse drug reactions, /. Pharm. Pract., 2, 239-244, 1989. 

---